hansoh glp-1 MSD enters into license agreement with Pharma for investigational Oral receptor agonist Hansoh discovers new GIPR, GCGR

Bayesian weighted Mendelian randomization for causal inference based on summary statistics

PT141 is generally not appropriate for clients with uncontrolled hypertension, significant cardiovascular disease, pregnancy, or for frequent use beyond labeled limits, so Better Med Spa screens carefully and uses conservative dosing and frequency

Patients who are also optimizing hormonal status should be aware that sex hormones interact with MOTS-c signaling

While the initial effects on appetite suppression are often seen within the first 1-2 weeks, significant and sustainable weight loss generally becomes noticeable after three to six months of consistent use